BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND B2M, P61769, 567, ENSG00000166710 AND Prognosis
26 results:

  • 1. CAF-associated genes putatively representing distinct prognosis by in silico landscape of stromal components of colon cancer.
    Okuno K; Ikemura K; Okamoto R; Oki K; Watanabe A; Kuroda Y; Kidachi M; Fujino S; Nie Y; Higuchi T; Chuman M; Washio M; Sakuraya M; Niihara M; Kumagai K; Sangai T; Kumamoto Y; Naitoh T; Hiki N; Yamashita K
    PLoS One; 2024; 19(4):e0299827. PubMed ID: 38557819
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Association between polyunsaturated fatty acids in adipose tissue and mortality of colorectal cancer patients.
    Roux-Levy C; Binquet C; Vaysse C; Scherrer ML; Ayav A; Ortega-Deballon P; Lakkis Z; Liu D; Deguelte S; Cottet V
    Nutrition; 2024 May; 121():112358. PubMed ID: 38401197
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Dentate line invasion as a predictive factor of poor distant relapse-free survival in locally advanced lower rectal cancer with anal sphincter involvement.
    Song M; Wang H; Wang L; Li S; Zhang Y; Geng J; Zhu X; Li Y; Cai Y; Wang W
    BMC Cancer; 2022 Nov; 22(1):1196. PubMed ID: 36403007
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Prognostic Value of Preoperative Serological Biomarkers in Patients Undergoing Curative-Intent Cytoreductive Surgery for colorectal cancer Peritoneal Metastases.
    El Asmar A; Delcourt M; Kamden L; Khaled C; Bohlok A; Moreau M; Sclafani F; Donckier V; Liberale G
    Ann Surg Oncol; 2023 Mar; 30(3):1863-1869. PubMed ID: 36350459
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Comparison of follow-up treatment regimens for colorectal cancer liver metastases without objective response to neoadjuvant chemotherapy: direct surgery or surgery after second-line chemotherapy].
    Lyu XY; Bi XY; Zhao H; Chen QC; Luo ZW; Zhang BL; Zhang XS; Cai JQ
    Zhonghua Wai Ke Za Zhi; 2022 May; 60(5):454-460. PubMed ID: 35359087
    [No Abstract]    [Full Text] [Related]  

  • 6. Treatment strategy for resectable colorectal cancer liver metastases from the viewpoint of time to surgical failure.
    Hirokawa F; Ueno M; Nakai T; Kaibori M; Nomi T; Iida H; Tanaka S; Komeda K; Hayami S; Kosaka H; Hokuto D; Kubo S; Uchiyama K
    Langenbecks Arch Surg; 2022 Mar; 407(2):699-706. PubMed ID: 34741671
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Association of Adiponectin and Vitamin D With Tumor Infiltrating Lymphocytes and Survival in Stage III Colon cancer.
    Sinicrope FA; Shi Q; Smyrk TC; Goldberg RM; Cohen SJ; Gill S; Kahlenberg MS; Nair S; Shield AF; Jahagirdar BN; Jacobson SB; Foster NR; Pollak MN; Alberts SR
    JNCI Cancer Spectr; 2021 Oct; 5(5):. PubMed ID: 34485815
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Oncological outcomes according to the treatment modality based on the size of rectal neuroendocrine tumors: a single-center retrospective study.
    Son J; Park IJ; Yang DH; Kim J; Kim KJ; Byeon JS; Hong SM; Kim YI; Kim JB; Lim SB; Yu CS; Kim JC
    Surg Endosc; 2022 Apr; 36(4):2445-2455. PubMed ID: 34009477
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. FDG-PET/CT in colorectal cancer: potential for vascular-metabolic imaging to provide markers of prognosis.
    Chen SH; Miles K; Taylor SA; Ganeshan B; Rodriquez M; Fraioli F; Wan S; Afaq A; Shortman R; Walls D; Hoy L; Endozo R; Bhargava A; Hanson M; Huang J; Raouf S; Francis D; Siddiqi S; Arulampalam T; Sizer B; Machesney M; Reay-Jones N; Dindyal S; Ng T; Groves AM
    Eur J Nucl Med Mol Imaging; 2021 Dec; 49(1):371-384. PubMed ID: 33837843
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Prognostic and diagnostic value of circRNA expression in colorectal carcinoma: a meta-analysis.
    Yuan J; Guo D; Li X; Chen J
    BMC Cancer; 2020 May; 20(1):448. PubMed ID: 32429931
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Total circulating cell-free DNA as a prognostic biomarker in metastatic colorectal cancer before first-line oxaliplatin-based chemotherapy.
    Hamfjord J; Guren TK; Dajani O; Johansen JS; Glimelius B; Sorbye H; Pfeiffer P; Lingjærde OC; Tveit KM; Kure EH; Pallisgaard N; Spindler KG
    Ann Oncol; 2019 Jul; 30(7):1088-1095. PubMed ID: 31046124
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Impact of primary tumour location and RAS/BRAF mutational status in metastatic colorectal cancer treated with first-line regimens containing oxaliplatin and bevacizumab: Prognostic factors from the AIO KRK0207 first-line and maintenance therapy trial.
    Hegewisch-Becker S; Nöpel-Dünnebacke S; Hinke A; Graeven U; Reinacher-Schick A; Hertel J; Lerchenmüller CA; Killing B; Depenbusch R; Al-Batran SE; Lange T; Dietrich G; Tannapfel A; Arnold D
    Eur J Cancer; 2018 Sep; 101():105-113. PubMed ID: 30036739
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Somatic mutations of the coding microsatellites within the beta-2-microglobulin gene in mismatch repair-deficient colorectal cancers and adenomas.
    Clendenning M; Huang A; Jayasekara H; Lorans M; Preston S; O'Callaghan N; Pope BJ; Macrae FA; Winship IM; Milne RL; Giles GG; English DR; Hopper JL; Win AK; Jenkins MA; Southey MC; Rosty C; Buchanan DD;
    Fam Cancer; 2018 Jan; 17(1):91-100. PubMed ID: 28616688
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Do inflammatory markers predict prognosis in patients with synchronous colorectal cancer?
    He W; Wei M; Yang X; Chen B; Wu Q; Zheng E; Deng X; Wang Z
    Medicine (Baltimore); 2017 Apr; 96(17):e6607. PubMed ID: 28445257
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The Characteristics and Prognostic Effect of E-Cadherin Expression in colorectal Signet Ring Cell Carcinoma.
    Wang R; Ma X; Li Y; He Y; Huang D; Cai S; Peng J
    PLoS One; 2016; 11(8):e0160527. PubMed ID: 27509205
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Semaphorin 4D and hypoxia-inducible factor-1α overexpression is related to prognosis in colorectal carcinoma.
    Wang JS; Jing CQ; Shan KS; Chen YZ; Guo XB; Cao ZX; Mu LJ; Peng LP; Zhou ML; Li LP
    World J Gastroenterol; 2015 Feb; 21(7):2191-8. PubMed ID: 25717256
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Multiple regression analysis of mRNA-miRNA associations in colorectal cancer pathway.
    Wang F; Wong SC; Chan LW; Cho WC; Yip SP; Yung BY
    Biomed Res Int; 2014; 2014():676724. PubMed ID: 24895601
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. [Correlation and clinical significance of expressions of HIF-1α and Sema4D in colorectal carcinoma tissues].
    Mu L; Wang J; Guo X; Zheng S; Shan K; Jing C; Li L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Apr; 17(4):388-92. PubMed ID: 24760652
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. [Pathogenesis of microsatellite-unstable colorectal cancer. Evaluation of new diagnostic and therapeutic options].
    Kloor M
    Pathologe; 2013 Nov; 34 Suppl 2():277-81. PubMed ID: 24196629
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Clinical significance of kallikrein-related peptidase (KLK10) mRNA expression in colorectal cancer.
    Alexopoulou DK; Papadopoulos IN; Scorilas A
    Clin Biochem; 2013 Oct; 46(15):1453-61. PubMed ID: 23499583
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.